Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26996 | 19373421 | Can J Gastroenterol | Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. | 2009 | Details |
A27000 | 19370776 | World J Gastroenterol | Olive oil consumption and non-alcoholic fatty liver disease. | 2009 | Details |
A27004 | 19366381 | J Am Acad Nurse Pract | Fatty liver in adolescents on the U.S.-Mexico border. | 2009 | Details |
A27005 | 19363256 | J Alzheimers Dis | Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. | 2009 | Details |
A27009 | 19360015 | Obesity (Silver Spring) | Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. | 2009 | Details |
A27011 | 19359149 | Nutr Metab Cardiovasc Dis | Hepatic lipid metabolism and non-alcoholic fatty liver disease. | 2009 | Details |
A27013 | 19355912 | Curr Mol Med | Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. | 2009 | Details |
A27014 | 19353360 | Ann Med | New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
A27015 | 19352614 | J Mol Med (Berl) | Molecular mechanisms involved in NAFLD progression. | 2009 | Details |
A27023 | 21495339 | Rev Med Chir Soc Med Nat Iasi | [Adipocytokines and nonalcoholic steatohepatitis]. | 2011 | Details |
A27026 | 19323780 | Liver Int | Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. | 2009 | Details |
A27030 | 19317274 | Acta Gastroenterol Belg | Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis. | 2009 | Details |
A27035 | 19293782 | Am J Gastroenterol | NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. | 2009 | Details |
A27038 | 19291292 | J Inflamm (Lond) | Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? | 2009 | Details |
A27044 | 19282820 | Obesity (Silver Spring) | Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. | 2009 | Details |
A27047 | 19278843 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. | 2009 | Details |
A27050 | 19268270 | Clin Gastroenterol Hepatol | Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. | 2009 | Details |
A27051 | 19267193 | Dig Dis Sci | Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation. | 2009 | Details |
A27053 | 19261002 | Hepatol Res | Role of hepatic iron in non-alcoholic steatohepatitis. | 2009 | Details |
A27054 | 19254570 | Cell Metab | The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. | 2009 | Details |
A27058 | 19246975 | J Endocrinol Invest | Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. | 2008 | Details |
A27060 | 19243311 | Clin Sci (Lond) | Metabolic disturbances in non-alcoholic fatty liver disease. | 2009 | Details |
A27061 | 19242728 | Pediatr Nephrol | Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. | 2009 | Details |
A27062 | 19240815 | Hippokratia | Non alcoholic fatty liver disease and metabolic syndrome. | 2009 | Details |
A27065 | 19230890 | Atherosclerosis | Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. | 2009 | Details |
A27066 | 19187068 | Liver Int | Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. | 2009 | Details |
A27072 | 19223251 | Dig Liver Dis | Non-alcoholic fatty liver disease pathogenesis: the present and the future. | 2009 | Details |
A27073 | 19222849 | BMC Gastroenterol | Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. | 2009 | Details |
A27076 | 19221666 | Ann Acad Med Singap | The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. | 2009 | Details |
A27077 | 19221529 | Ann Hepatol | Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). | 2009 | Details |
A27078 | 19221528 | Ann Hepatol | Hepatogenous diabetes. Current views of an ancient problem. | 2009 | Details |
A27082 | 19215335 | J Gastroenterol Hepatol | An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2009 | Details |
A27086 | 19202511 | Pediatr Endocrinol Rev | Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. | 2008 | Details |
A27089 | 19195630 | Diabetes Metab | Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. | 2008 | Details |
A27091 | 19195628 | Diabetes Metab | How to measure hepatic insulin resistance? | 2008 | Details |
A27093 | 19195625 | Diabetes Metab | The role of the lipogenic pathway in the development of hepatic steatosis. | 2008 | Details |
A27096 | 19194305 | Eur J Gastroenterol Hepatol | Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. | 2009 | Details |
A27097 | 19184102 | Eur J Pediatr | Nonalcoholic fatty liver disease during valproate therapy. | 2009 | Details |
A27098 | 19183714 | Paediatr Child Health | Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease. | 2008 | Details |
A27099 | 19181602 | J Formos Med Assoc | Non-alcoholic steatohepatitis: an overview. | 2009 | Details |
A27100 | 19177596 | Hepatology | Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. | 2009 | Details |
A27102 | 19171337 | Fertil Steril | Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome. | 2009 | Details |
A27104 | 19166967 | Biochim Biophys Acta | Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. | 2009 | Details |
A27106 | 19165171 | Obesity (Silver Spring) | Liver NF-kappaB and AP-1 DNA binding in obese patients. | 2009 | Details |
A27111 | 19155426 | J Am Coll Nutr | Nonalcoholic fatty liver disease in children. | 2008 | Details |
A27113 | 19152453 | World J Gastroenterol | Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents. | 2009 | Details |
A27114 | 19147984 | J Clin Invest | Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. | 2009 | Details |
A27116 | 19142989 | Hepatology | Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. | 2009 | Details |
A27119 | 19140227 | World J Gastroenterol | Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. | 2009 | Details |
A27122 | 19137372 | Mamm Genome | Genetic factors for resistance to diet-induced obesity and associated metabolic traits on mouse chromosome 17. | 2009 | Details |
A27124 | 19131466 | Diabetes Care | Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. | 2009 | Details |
A27135 | 20469672 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy]. | 2009 | Details |
A27136 | 20387270 | J Alzheimers Dis | Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. | 2009 | Details |
A27138 | 19110662 | Turk J Gastroenterol | Factors related to non-alcoholic fatty liver disease in obese children. | 2008 | Details |
A27140 | 19105201 | Hepatology | Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. | 2009 | Details |
A27145 | 19088402 | Endocr J | A novel mouse model for type 2 diabetes and non-alcoholic fatty liver disease: spontaneous amelioration of diabetes by augmented beta cell mass. | 2008 | Details |
A27148 | 19084941 | World J Gastroenterol | Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. | 2008 | Details |
A27149 | 19077512 | Korean J Gastroenterol | [Clinical characteristics of health screen examinees with nonalcoholic fatty liver and normal liver function test]. | 2008 | Details |
A27151 | 19075784 | Endocr Metab Immune Disord Drug Targets | Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk? | 2008 | Details |
A27154 | 19073452 | Orv Hetil | [Silymarin in the treatment of chronic liver diseases: past and future]. | 2008 | Details |
A27157 | 19072356 | Expert Rev Gastroenterol Hepatol | Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C. | 2008 | Details |
A27158 | 19072347 | Expert Rev Gastroenterol Hepatol | Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. | 2008 | Details |
A27162 | 19067776 | J Gastroenterol Hepatol | Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. | 2008 | Details |
A27164 | 19058085 | Scand J Gastroenterol | Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. | 2009 | Details |
A27169 | 19053946 | Clin Sci (Lond) | Magic angle spinning magnetic resonance: a novel method opening up translational research into NAFLD? | 2009 | Details |
A27171 | 19051794 | Ned Tijdschr Geneeskd | [Non-alcoholic fatty liver disease in children: a new complication of obesity]. | 2008 | Details |
A27174 | 19035982 | Aliment Pharmacol Ther | Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. | 2008 | Details |
A27176 | 19034256 | Minerva Med | Nonalcoholic fatty liver disease. | 2008 | Details |
A27177 | 19034237 | Ann Hepatol | Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery. | 2009 | Details |
A27181 | 19027869 | Int J Biochem Cell Biol | Non-alcoholic steatohepatitis and animal models: understanding the human disease. | 2008 | Details |
A27183 | 19025308 | Rev Esp Enferm Dig | [Molecular basis of obesity-related hepatic steatosis]. | 2008 | Details |
A27184 | 19022218 | Arch Biochem Biophys | PKCepsilon plays a causal role in acute ethanol-induced steatosis. | 2008 | Details |
A27187 | 19016382 | Scand J Gastroenterol | Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. | 2009 | Details |
A27192 | 19013572 | Atherosclerosis | Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. | 2008 | Details |
A27196 | 19005759 | Dig Dis Sci | Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease. | 2008 | Details |
A27198 | 19002423 | Internist (Berl) | [Are there therapeutic approaches of non-alcoholic fatty liver disease and its complications?]. | 2008 | Details |
A27207 | 18984944 | Respiration | Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. | 2008 | Details |
A27214 | 18972077 | Adv Ther | Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? | 2008 | Details |
A27216 | 18956298 | Semin Liver Dis | Effects of weight loss on nonalcoholic fatty liver disease. | 2008 | Details |
A27217 | 18956297 | Semin Liver Dis | Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. | 2008 | Details |
A27218 | 18956296 | Semin Liver Dis | Current and emerging therapies in nonalcoholic fatty liver disease. | 2008 | Details |
A27221 | 18956293 | Semin Liver Dis | Mechanisms of disease progression in nonalcoholic fatty liver disease. | 2008 | Details |
A27222 | 18956292 | Semin Liver Dis | Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. | 2008 | Details |
A27223 | 18956291 | Semin Liver Dis | Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. | 2008 | Details |
A27226 | 18950580 | Med Sci (Paris) | [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP]. | 2008 | Details |
A27227 | 18949388 | Int J Mol Med | The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. | 2008 | Details |
A27228 | 18948971 | Obesity (Silver Spring) | Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. | 2008 | Details |
A27230 | 18945255 | Aliment Pharmacol Ther | Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. | 2008 | Details |
A27231 | 18942340 | Pol Merkur Lekarski | [Non invasive markers of non-alcoholic steatohepatitis]. | 2008 | Details |
A27233 | 18939388 | Cleve Clin J Med | Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. | 2008 | Details |
A27235 | 18936912 | Naunyn Schmiedebergs Arch Pharmacol | A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia. | 2008 | Details |
A27236 | 18929493 | Trends Endocrinol Metab | Insulin resistance, inflammation, and non-alcoholic fatty liver disease. | 2008 | Details |
A27240 | 18925303 | Can J Gastroenterol | Soft drink consumption linked with fatty liver in the absence of traditional risk factors. | 2008 | Details |
A27241 | 18922966 | Pharmacol Rev | Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. | 2008 | Details |
A27242 | 18854760 | J Hypertens | Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. | 2008 | Details |
A27247 | 18844098 | Zhonghua Yi Xue Za Zhi | [Relationship of liver fat content to insulin resistance and metabolic syndrome]. | 2008 | Details |
A27248 | 18839055 | Acta Diabetol | Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease. | 2008 | Details |
A27249 | 18839053 | Acta Diabetol | The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. | 2008 | Details |
A27251 | 18835952 | Diabetes Care | Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. | 2008 | Details |
A27262 | 18813860 | Int J Mol Med | Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study. | 2008 | Details |